The Usefulness of Laboratory Tests in the Early Assessment of Severity of Acute Pancreatitis

REFERENCES

• Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993; 128: 586–90.
   Google Scholar
• Imrie CW. Underdiagnosis of acute pancreatitis. Adv Acute Pancreatitis 1997; 1: 3–5.
   Google Scholar
• Foitzik T, Klar E, Buhr HJ, et al. Improved survival in necrotizing pancreatitis despite limiting the indications for surgical debridement. Eur J Surg 1995; 161: 187–92.
   PubMedGoogle Scholar
• Brivet FG, Emilie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999; 27: 749–55.
   PubMed Web of Science ®Google Scholar
• Larvin M. McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; 2: 201–5.
   PubMedGoogle Scholar
• Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77: 1260–4.
   PubMed Web of Science ®Google Scholar
• Corfield AP, Cooper MJ, Williamson RC, et al. Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet 1985; 2: 403–7.
   PubMed Web of Science ®Google Scholar
• McMahon MJ, Playforth MJ, Pickford IR. A comparative study of methods for the prediction of severity of attacks of acute pancreatitis. Br J Surg 1980; 67: 22–5.
   PubMed Web of Science ®Google Scholar
• Heath DI, Imrie CW. The Hong Kong criteria and severity prediction in acute pancreatitis. Int J Pancreatol 1994; 15: 179–85.
   PubMedGoogle Scholar
• Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 2001; 164: 162–170.
   PubMed Web of Science ®Google Scholar
• Ranson JHC, Rifkind KM, Roses DF, et al. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139: 69–81.
   PubMedGoogle Scholar
• Blamey SL, Imrie CW, O’Neill J, et al. Prognostic factors in acute pancreatitis. Gut 1984; 25: 1340–6.
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955–60.
   PubMed Web of Science ®Google Scholar
• Wilson C, Heads A, Shenkin A, et al. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76: 177–81.
   PubMed Web of Science ®Google Scholar
• Steinberg WM. Predictors of severity of acute pancreatitis. Gastroenterol Clin North Am 1990; 19: 849–61.
   PubMed Web of Science ®Google Scholar
• Bradley EL 3rd, Murphy F, Ferguson C. Prediction of pancreatic necrosis by dynamic pancreatography. Ann Surg 1989; 210: 495–503.
   PubMedGoogle Scholar
• Balthazar EJ, Ranson JH, Naidich DP, et al. Acute pancreatitis: prognostic value of CT. Radiology 1985; 156: 767–72.
   PubMed Web of Science ®Google Scholar
• London NJ, Neoptolemos JP, Lavelle J, et al. Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis: a prospective study. Br J Surg 1989; 76: 268–72.
   PubMed Web of Science ®Google Scholar
• Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174: 331–6.
   PubMed Web of Science ®Google Scholar
• Foitzik T, Bassi DG, Schmidt J, et al. Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the rat. Gastroenterology 1994; 106: 207–14.
   PubMedGoogle Scholar
• Schmidt J, Hotz HG, Foitzik T, et al. Intravenous contrast medium aggravates the impairment of pancreatic microcirculation in necrotizing pancreatitis in the rat. Ann Surg 1995; 221: 257–64.
   PubMedGoogle Scholar
• Carmona-Sanchez R, Uscanga L, Bezaury-Rivas P, et al. Potential harmful effect of iodinated intravenous contrast medium on the clinical course of mild acute pancreatitis. Arch Surg 2000; 135: 1280–4.
   PubMedGoogle Scholar
• van den Biezenbos AR, Kruyt PM, Bosscha K, et al. Added value of CT criteria compared to the clinical SAP score in patients with acute pancreatitis. Abdom Imaging 1998; 23: 622–6.
   PubMedGoogle Scholar
• Clavien PA, Hauser H, Meyer P, et al. Value of contrast-enhanced computerized tomography in the early diagnosis and prognosis of acute pancreatitis. A prospective study of 202 patients. Am J Surg 1988; 155: 457–66.
   PubMedGoogle Scholar
• Balthazar EJ, Freeny PC, van Sonnenberg E. Imaging and intervention in acute pancreatitis. Radiology 1994; 193: 297–306.
   PubMed Web of Science ®Google Scholar
• Viedma JA, Perez-Mateo M, Dominguez JE, et al. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992; 33: 1264–1267.
   PubMedGoogle Scholar
• Viedma JA, Perez-Mateo M, Agullo J, et al. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994; 35: 822–7.
   PubMed Web of Science ®Google Scholar
• Paajanen H, Laato M, Jaakkola M, et al. Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg 1995; 82: 271–273.
   PubMed Web of Science ®Google Scholar
• Kylanpaa-Back ML, Takala A, Kemppainen E, et al. Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 2001; 88: 222–7.
   PubMed Web of Science ®Google Scholar
• Lempinen M, Kylanpaa-Back ML, Stenman, UH, et al. Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine. Clin Chem 2001; 47: 2103–7.
   PubMed Web of Science ®Google Scholar
• Rau B, Cebulla M, Uhl W, et al. The clinical value of human pancreas-specific protein procarboxypeptidase B as an indicator of necrosis in acute pancreatitis: comparison to CRP and LDH. Pancreas 1998; 17: 134–9.
   PubMed Web of Science ®Google Scholar
• Gross V, Scholmerich J, Leser HG, et al. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-anti-trypsin, and protease inhibitor alpha 2-macroglobulin. Dig Dis Sci 1990; 35: 97–105.
   PubMed Web of Science ®Google Scholar
• Uhl W, Buchler M, Malfertheiner P, et al. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6: 253–9.
   PubMed Web of Science ®Google Scholar
• Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982; 77: 633–8.
   PubMed Web of Science ®Google Scholar
• Pezzilli R, Billi P, Miglioli M, et al. Serum amylase and lipase concentrations and lipase/ amylase ratio in assessment of etiology and severity of acute pancreatitis. Dig Dis Sci 1993; 38: 1265–9.
   PubMedGoogle Scholar
• Keim V. Loffler HG. Pancreatitis-associated protein in bile acid-induced pancreatitis of the rat. Clin Physiol Biochem 1986; 4: 136–42.
   PubMedGoogle Scholar
• Iovanna JL. Keim V. Nordback I, et al. Serum levels of pancreatitis-associated protein as indicators of the course of acute pancreatitis. Multicentric Study Group on Acute Pancreatitis. Gastroenterology 1994: 106: 728–34.
   PubMed Web of Science ®Google Scholar
• Kemppainen E, Sand J, Puolakkainen P, et al. Pancreatitis associated protein as an early marker of acute pancreatitis. Gut 1996; 39: 675–8.
   PubMed Web of Science ®Google Scholar
• Pezzilli R, Billi P, Migliori M, et al. Clinical value of pancreatitis-associated protein in acute pancreatitis. Am J Gastroenterol 1997; 92: 1887–90.
   PubMedGoogle Scholar
• Pousette A, Fernstad R, Skoldefors H, et al. Novel assay for pancreatic cellular damage. 1. Characterization of protein profiles in human pancreatic cytosol and purification and characterization of a pancreatic specific protein. Pancreas 1988; 3: 421–6.
   PubMed Web of Science ®Google Scholar
• Pousette A, Fernstad R, Skoldefors H, et al. A novel serum assay for pancreatic cellular damage. II. High tissue specificity of a pancreatic protein. Pancreas 1988; 3: 642–5.
   PubMed Web of Science ®Google Scholar
• Yamamoto KK, Pousette A, Chow P, et al. Isolation of a cDNA encoding a human serum marker for acute pancreatitis. Identification of a pancreas-specific protein as pancreatic procarboxypeptidase B. J Biol Chem 1992; 267: 2575–81.
   PubMedGoogle Scholar
• Fernstad R, Pousette A, Carlstrom K, et al. A novel assay for pancreatic cellular damage: IV. Serum concentrations of pancreas-specific protein (PASP) in acute pancreatitis and other abdominal diseases. Pancreas 1990; 5: 42–9.
   PubMed Web of Science ®Google Scholar
• Nyberg G, Olausson M, Norden D, et al. Pancreas-specific protein: Monitoring in pancreas transplantation. Transplant Proc 1991; 23: 1604–5.
   PubMedGoogle Scholar
• Fernstad R, Tyden G, Brattstrom C, et al. Pancreas-specific protein. New serum marker for graft rejection in pancreas-transplant recipients. Diabetes 1989; 38 S1: 55–6.
   PubMedGoogle Scholar
• Printz H, Siegmund H, Wojte C, et al. “Human pancreas-specific protein” (procarboxypeptidase B): a valuable marker in pancreatitis? Pancreas 1995; 10: 222–30.
   Google Scholar
• Chen CC, Wang SS, Chao Y, et al. Serum pancreas-specific protein in acute pancreatitis. Its clinical utility in comparison with serum amylase. Scand J Gastroenterol 1994; 29: 87–90.
   PubMed Web of Science ®Google Scholar
• Pezzilli R, Billi P, Plate L, et al. Human pancreas-specific protein/procarboxypeptidase B: a useful serum marker of acute pancreatitis. Digestion 1994; 55: 73–7.
   PubMedGoogle Scholar
• Appelros S, Thim L, Borgstrom A. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut 1998; 42: 97–102.
   PubMedGoogle Scholar
• Appelros S. Lindgren S. Borgstrom A. Short and long term outcome of severe acute pancreatitis. Eur J Surg 2001; 167: 281–6.
   PubMedGoogle Scholar
• Ohlsson K, Balldin G, Bohe M, et al. Pancreatic proteases and antiproteases in pancreatic disease; biochemical, pathophysiological and clinical aspects. Int J Pancreatol 1988; 3: S67–8.
   Google Scholar
• Itkonen O, Koivunen E, Hurme M, et al. Time-resolved immunofluorometric assays for trypsinogen-1 and -2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990; 115: 712–8.
   PubMed Web of Science ®Google Scholar
• Hedstrom J, Leinonen J, Sainio V, et al. Time-resolved immunofluorometric assay of trypsin-2 complexed with alpha 1-antitrypsin in serum. Clin Chem 1994; 40: 1761–5.
   PubMed Web of Science ®Google Scholar
• Hedstrom J, Sainio V, Kemppainen E, et al. Urine trypsinogen-2 as marker of acute pancreatitis. Clin Chem 1996; 42: 685–90.
   PubMed Web of Science ®Google Scholar
• Hedstrom J, Kemppainen E, Andersen J, et al. A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis. Am J Gastroenterol 2001; 96: 424–30.
   PubMed Web of Science ®Google Scholar
• Sainio V, Puolakkainen P, Kemppainen E, et al. Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis. Scand J Gastroenterol 1996; 31: 818–24.
   PubMed Web of Science ®Google Scholar
• Hurley PR, Cook A, Jehanli A, et al. Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP). J Immunol Methods 1988; 111: 195–203.
   PubMedGoogle Scholar
• Gudgeon AM, Heath DI, Hurley P, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990; 335: 4–8.
   PubMed Web of Science ®Google Scholar
• Tenner S, Fernandez-del Castillo C, Warshaw A, et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997; 21: 105–10.
   PubMedGoogle Scholar
• Mayer J, Sumar N, Schoenberg MH, et al. A new immunoassay for I-Phospholipase A2 activation peptide PROP in acute inflammatory diseases. Eur Surg Res 1996; 28: 90.
   Google Scholar
• Kemppainen E, Mayer J, Puolakkainen P, et al. Plasma trypsinogen activation peptide in patients with acute pancreatitis. Br J Surg 2001; 88: 679–80.
   PubMedGoogle Scholar
• Mayer J, Rau B, Schoenberg MH, et al. Mechanism and role of trypsinogen activation in acute pancreatitis. Hepatogastroenterology 1999; 46: 2757–63.
   PubMedGoogle Scholar
• Banks PA. Acute and chronic pancreatitis. In: Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. W.B. Saunders Company, Philadelphis, 1998. pp. 809–62.
   Google Scholar
• Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991; 101: 782–785.
   PubMed Web of Science ®Google Scholar
• Mayer J, Rau B, Gansauge F, et al. Imflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47: 546–552.
   PubMed Web of Science ®Google Scholar
• McKay CJ, Gallagher G, Brooks B, et al. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996; 83: 919–923.
   PubMed Web of Science ®Google Scholar
• De Beaux AC, Ross JA, Maingay JP, et al. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg 1996; 83: 1071–1075.
   PubMedGoogle Scholar
• De Beaux AC, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996; 83: 349–353.
   PubMedGoogle Scholar
• Chen CC, Wang SS, Lee FY, et al. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999; 94: 213–218.
   PubMed Web of Science ®Google Scholar
• Heath DI, Cruickshank A, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41–45.
   PubMed Web of Science ®Google Scholar
• Pezzilli R, Billi P, Miniero R, et al. Serum interleukin-6, interleukin-8, and ?2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 1995; 40: 2341–2348.
   PubMed Web of Science ®Google Scholar
• Gross V, Andreesen R, Leser HG, et al. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992; 22: 200–203.
   PubMed Web of Science ®Google Scholar
• Norman JG, Fink G, Franz M, et al. Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg 1996; 223: 163–169.
   PubMedGoogle Scholar
• Heresbach D, Letourneur JP, Bahon I, et al. Value of early blood Th-1 cytokine determination in predicting severity of acute pancreatitis. Scand J Gastroenterol 1998; 33: 554–560.
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Tilz GP, Lueger A, Demel U. Elevated plasma levels of soluble tumor necrosis factor receptor (sTNFRp60) reflect severity of acute pancreatitis. Intensive Care Med 1997; 23: 841–848.
   PubMed Web of Science ®Google Scholar
• Hoffmann GE, Schmidt D, Bastian B, et al. Photometric determination of phospholipase A. J Clin Chem Clin Biochem 1986; 24: 871–5.
   PubMedGoogle Scholar
• Schadlich HR, Buchler M, Beger HG. Improved method for the determination of phospholi-pase A2 catalytic activity concentration in human serum and ascites. J Clin Chem Clin Biochem 1987; 25: 505–9.
   PubMedGoogle Scholar
• Makela A, Kuusi T, Somerharju P, et al. A simple isotopic assay method for human serum phospholipase A2 activity. Scand J Clin Lab Inv 1987; 47: 529–34.
   PubMed Web of Science ®Google Scholar
• Nevalainen TJ, Kortesuo PT, Rintala E, et al. Immunochemical detection of group I and group II phospholipases A2 in human serum. Clin Chem 1992; 38:1824-9.
   PubMedGoogle Scholar
• Santavuori SA, Kortesuo PT, Eskola JU, et al. Application of a new monoclonal antibody for time-resolved fluoroimmunoassay of human pancreatic phospholipase A2. Eur J Clin Chem Clin Biochem 1991; 29: 819–26.
   PubMedGoogle Scholar
• Buchler M, Malfertheiner P, Schadlich H, et al. Role of phospholipase A2 in human acute pancreatitis. Gastroenterology 1989; 97: 1521–6.
   PubMed Web of Science ®Google Scholar
• Gronroos JM, Nevalainen TJ. Increased concentrations of synovial-type phospholipase A2 in serum and pulmonary and renal complications in acute pancreatitis. Digestion 1992; 52: 232–6.
   PubMedGoogle Scholar
• Nevalainen TJ, Gronroos JM, Kortesuo PT. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis. Gut 1993; 34: 1133–6.
   PubMed Web of Science ®Google Scholar
• Makela A, Kuusi T, Schroder T. Serum phospholipase A2, amylase, lipase, and urinary amylase activities in relation to the severity of acute pancreatitis. Eur J Surg 1997; 163: 915–22.
   PubMedGoogle Scholar
• Mayer J, Rau B, Grewe M et al. Secretory phospholipase A2 in patients with infected pancreatic necroses in acute pancreatitis. Pancreas 1998; 17: 272–7.
   PubMed Web of Science ®Google Scholar
• Gronroos JM, Hietaranta AJ, Nevalainen TJ. Renal tubular cell injury and serum phospholi-pase A2 activity in acute pancreatitis. Br J Surg 1992; 79: 800–1.
   PubMed Web of Science ®Google Scholar
• Gukovskaya AS, Vaquero E, Zaninovic V, et al. Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis. Gastroenterology 2002; 122: 974–84.
   PubMed Web of Science ®Google Scholar
• Dominguez-Munoz JE, Carballo F, Garcia MJ, et al. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study. Br J Surg 1991; 78: 1230–4.
   PubMed Web of Science ®Google Scholar
• Berney T, Gasche Y, Robert J, et al. Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas 1999; 18: 371–7.
   PubMed Web of Science ®Google Scholar
• Hensel M, Volk T, Docke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998; 89: 93–104.
   PubMed Web of Science ®Google Scholar
• Rau B, Steinbach G, Gansauge F, et al. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41: 832–40.
   PubMed Web of Science ®Google Scholar
• Windsor AC, Kanwar S, Li AG, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998; 42: 431–5.
   PubMed Web of Science ®Google Scholar
• Kalfarentzos F, Kehagias J, Mead N, et al. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 1997; 84: 1665–9.
   PubMed Web of Science ®Google Scholar
• Ho HS, Frey CF. The role of antibiotic prophylaxis in severe acute pancreatitis. Arch Surg 1997; 132: 487–92.
   PubMedGoogle Scholar
• Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993; 176: 480–3.
   PubMedGoogle Scholar
• Fan ST, Lai ECS, Mok FPT, et al. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med 1993; 328: 228–32.
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP, Carr-Locke DL, London NJ, et al. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 1988; 2: 979–83.
   PubMed Web of Science ®Google Scholar